355 related articles for article (PubMed ID: 23806156)
1. Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.
Lo Schiavo A; Ruocco E; Brancaccio G; Caccavale S; Ruocco V; Wolf R
Clin Dermatol; 2013; 31(4):391-399. PubMed ID: 23806156
[TBL] [Abstract][Full Text] [Related]
2. Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies.
Ruocco V; Ruocco E; Lo Schiavo A; Brunetti G; Guerrera LP; Wolf R
Clin Dermatol; 2013; 31(4):374-381. PubMed ID: 23806154
[TBL] [Abstract][Full Text] [Related]
3. A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
Amber KT; Zikry J; Hertl M
HLA; 2017 Mar; 89(3):127-134. PubMed ID: 28101965
[TBL] [Abstract][Full Text] [Related]
4. New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update.
Genovese G; Di Zenzo G; Cozzani E; Berti E; Cugno M; Marzano AV
Front Immunol; 2019; 10():1506. PubMed ID: 31312206
[TBL] [Abstract][Full Text] [Related]
5. Bullous Pemphigoid: Trigger and Predisposing Factors.
Moro F; Fania L; Sinagra JLM; Salemme A; Di Zenzo G
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050407
[TBL] [Abstract][Full Text] [Related]
6. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.
Nishie W
J Dermatol Sci; 2014 Mar; 73(3):179-86. PubMed ID: 24434029
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity in bullous pemphigoid.
Wong MM; Giudice GJ; Fairley JA
G Ital Dermatol Venereol; 2009 Aug; 144(4):411-21. PubMed ID: 19755944
[TBL] [Abstract][Full Text] [Related]
8. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
10. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
[TBL] [Abstract][Full Text] [Related]
11. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
[TBL] [Abstract][Full Text] [Related]
12. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
van Beek N; Schulze FS; Zillikens D; Schmidt E
Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
[TBL] [Abstract][Full Text] [Related]
14. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers related to bullous pemphigoid activity and outcome.
Giusti D; Le Jan S; Gatouillat G; Bernard P; Pham BN; Antonicelli F
Exp Dermatol; 2017 Dec; 26(12):1240-1247. PubMed ID: 29105148
[TBL] [Abstract][Full Text] [Related]
17. Role of MHC Class II genes in the pathogenesis of pemphigoid.
Zakka LR; Reche P; Ahmed AR
Autoimmun Rev; 2011 Nov; 11(1):40-7. PubMed ID: 21782980
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
19. Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.
Bernard P; Antonicelli F
Am J Clin Dermatol; 2017 Aug; 18(4):513-528. PubMed ID: 28247089
[TBL] [Abstract][Full Text] [Related]
20. From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.
de Nicolas-Ruanes B; Ballester-Martinez A; Garcia-Mouronte E; Berna-Rico E; Azcarraga-Llobet C; Fernandez-Guarino M
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
